On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayOct 24, 2017 9:41 am

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Highlights Positive Pre-Clinical Data Related to Biosynthesis Platform

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced results from a study co-sponsored by InMed and the University of British Columbia. Notably, this study is the first ever to report hydrogel-mediated cannabinoid nanoparticle delivery to the eye resulting in enhanced drug uptake via the cornea and lens. “Importantly, this study offers further validation of InMed's capabilities in moving the science of cannabinoid pharmaceuticals forward,” Eric A. Adams, president and CEO of InMed, stated in the news release. “Results like this, combined with our expanding patent portfolio and list of publications, on-going R&D, and renowned…

Continue Reading

MondayOct 23, 2017 9:56 am

CannabisNewsBreaks – Global Payout, Inc. (GOHE) Enters Final Stages of Audit in Preparation for Uplisting to OTCQB Venture Marketplace

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that it is in the final stages of performing a two-year audit in an effort to become a fully reporting SEC company. Upon completion of the audit, Global Payout will immediately apply for listing on the OTCQB Venture Marketplace. “We have been contemplating an up-list to the OTCQB for quite some time and we as a Company feel that now is the best time given Global’s progress over the past few months,” Jim Hancock, CEO of Global Payout, stated in the news release. “The recent acquisition of two revenue…

Continue Reading

FridayOct 20, 2017 11:59 am

CannabisNewsBreaks – Green Spirit Industries, Inc. (GSRX) Fast-Tracks Dispensary Construction on Three Pre-Approved Sites in Puerto Rico Following Hurricane Maria

Green Spirit Industries (OTC: GSRX) this morning said it has ramped up its construction efforts regarding three pre-approved medical cannabis dispensaries in Puerto Rico following Hurricane Maria. Green Spirit has brought in additional workforce to help complete the locations in Dorado, Carolina and San Juan for inspection and intends to open the locations before year end. “Patients in Puerto Rico who have come to depend upon medical marijuana, especially those for whom it replaces pharmaceuticals, need safe and dependable dispensaries that are conveniently located, and it is our aim to help fill the need as quickly as possible,” Green Spirit…

Continue Reading

ThursdayOct 19, 2017 12:24 pm

CannabisNewsBreaks – Canada’s Cannabis Market Presents Big Potential for Algae Dynamics Corp. (ADYNF)

In Canada, where recreational marijuana is expected to be legalized in 2018 and where registered clients are projected to increase to 715,000 by 2020 and cumulatively purchase 124,443 kg of dried medical marijuana annually, Algae Dynamics Corp. (OTCQB: ADYNF) foresees huge opportunity and greater market share. If the model seen in Colorado’s cannabis market holds true, by 2018 approximately 45 percent of Canada’s cannabis consumers will have switched from dried medical marijuana to cannabis extracts/oil. This is great news for ADYNF, which produces health products and nutraceuticals utilizing cannabis, hemp and algae oils. An article discussing this reads: “(ADYNF) is…

Continue Reading

ThursdayOct 19, 2017 12:24 pm

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Poised to be First to Market in China’s Multibillion-Dollar Skin Care Industry with Line of Cannabidiol-Based Products

ChineseInvestors.com (OTCQB: CIIX) is quickly moving into the multibillion-dollar Chinese skin care industry and is introducing its first line of cannabidiol (CBD) based skin care products. CIIX has already filed a record with the China Food and Drug Administration for this line of hemp-infused skin care products and hopes to launch within the next couple of months. An article discussing this reads: “China is the second-largest consumer of skin care products in the world and generates nearly $30 billion in annual retail sales. Since no other notable manufacturers have entered the cannabis skin care product market in China, CIIX would…

Continue Reading

ThursdayOct 19, 2017 12:24 pm

CannabisNewsBreaks – Marijuana Company of America (MCOA) Stands Out among Cannabis and Hemp Industry Innovators

Constant growth within the legal marijuana and hemp industries also means increasingly fierce competition in this burgeoning market, which makes it more and more difficult for companies in the cannabis space to stand out from the pack. Marijuana Company of America, Inc. (OTC: MCOA) is among those managing to shine in spite of the growing competition, successfully carving out a niche with its unique, strategic approach and distinctive business model. An article discussing this reads: “The exponential growth of the legal cannabis market and the hemp-based CBD industry enables Marijuana Company of America to fully develop its vertically integrated business…

Continue Reading

WednesdayOct 18, 2017 2:43 pm

CannabisNewsBreaks – SinglePoint, Inc. (SING) CEO Featured in Equities.com Interview

SinglePoint (OTC: SING) was featured in an article published by Equities.com in which the company’s chief executive officer, Greg Lambrecht, was interviewed. SinglePoint is a full-service mobile technology provider focused on horizontal markets and acquiring undervalued subsidiaries. The company is currently engaged in two booming industries: cannabis and cryptocurrency. “We believe that when we get through with our cryptocurrency product we're going to have a huge first mover advantage to be able to go into the dispensary and let the customers use Bitcoin or other coins to pay for cannabis. It’s just a huge opportunity and with our technical expertise…

Continue Reading

WednesdayOct 18, 2017 11:29 am

CannabisNewsBreaks – Pressure BioSciences, Inc. (PBIO) Enters Collaboration Agreement with Phasex Corporation

Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO), a leader in the development and sale of innovative solutions for the worldwide life sciences industry, this morning announced a collaboration with Phasex Corporation, one of the world’s most experienced supercritical fluid (“SCF”)-based toll processors. The goal of the collaboration is to combine PBI’s recently patented Ultra Shear Technology with Phasex’s SCF-based processing methods to enable the development of stable, water-soluble nanoemulsions of nutraceuticals, including CBD-enriched plant oil. “Rapidly expanding markets for non-psychoactive extracts of cannabis plant material, for instance, is an example of a potentially high demand application for our combined, synergistic technologies,” Richard…

Continue Reading

WednesdayOct 18, 2017 10:43 am

CannabisNewsBreaks – EVIO, Inc. (EVIO) Announces Strong Start to Fiscal 2018

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing services, this morning announced that its EVIO Labs division has already exceeded last October’s testing revenues through the first half of October 2017, with sales surpassing $250,000. “Our national sales team continues to expand EVIO's service offerings,” William Waldrop, CEO of EVIO, stated in the news release. “After an impressive 2017, in which we exceeded our own internal projections, we are starting the 2018 fiscal year on the right track. We are eagerly waiting for the upcoming accreditation of our new pesticide equipment. As mentioned in our 8K, the…

Continue Reading

WednesdayOct 18, 2017 9:33 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Approaching Commercialization of IGC-AD1 in Early 2018

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model showing that, at varying concentrations of IGC-AD1, the expression of GSK3β is reduced by as much as 62 percent. “Based on this and other previously announced compelling data, we are readying IGC-AD1, brand name Hyalolex, in a liquid formulation for commercialization in early 2018,” Ram Mukunda, CEO of IGC, stated in the news release. “We have identified Germany, Canada and certain licensed medical…

Continue Reading

Contact us: 303.498.7722